Published Date: 08 Mar 2023
A groundbreaking study by the University of Bristol and the University of Essex has revealed new insights into the importance of early childhood for lung health.
Read Full NewsIn high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.
Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.
1.
FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC
2.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
3.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
4.
In women with extremely dense breasts, elevated MRI enhancement can help identify cancer risk.
5.
Research indicates that combining AI models enhances the ability to predict breast cancer risk.
1.
Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment
2.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
3.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
4.
Integrated Strategies in Oncology for Modern Medicine
5.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation